Supplementary Figures
. A scheme for the synthesis of hyaluronic acid-bilirubin conjugate (HA-BR). Supplementary Figure 2 . NMR spectra of HA-BR, hyaluronic acid (HA), and bilirubin (BR). Supplementary Figure 3 . Characterization of HA-BR and HABN. a, Solubility or dispersibility of HA (3 mg/ml), BR (100 µg/ml), or HABN (3 mg/ml), in water, CHCl3, or DMSO. b, UV/Vis spectra of HABN (1 mg/ml; BR 25 µg/ml in suspension) and BR (10 µg/ml and 100 µg/ml). c-d, Hydrodynamic sizes (c) and zeta potential values (d) of 10K HABN, 100K HABN, and 700K HABN. Data are presented as mean ± s.d. from a representative experiment (n = 3 biologically independent samples) from 2 independent experiments. Figure 4 . ROS-mediated decomposition of HABN. a, Changes in the size of HABNs (in PBS) induced by ROS stimuli, as determined by dynamic light scattering. HABNs were exposed to a peroxy radical generator AAPH (100 mM), H2O2 (5 mM), or NaOCl (1 mM). b, UV/VIS spectra of 100K HABN (1 mg/ml) in PBS treated with 100 mM of AAPH, 5 mM of H2O2, or 1 mM of NaOCl over 1 h. Data are presented as mean ± s.d. from a representative experiment (n = 3 biologically independent samples) from 2 independent experiments. a, Healthy or DSS-colitis mice were orally administered on day 6 with 7.5 mg/kg of HA-Cy5.5, HACN-Cy5.5, or HABN-Cy5.5 (equivalent mass of Cy5.5), and colon tissues were excised after 6 h, stained with anti-F4/80 and anti-b-catenin antibodies, and visualized by confocal microscopy. Scale bars = 50 µm. b, Colon tissues obtained from mice given 3% DSS water for 6 days and orally administered with HABN-Cy5.5 (7.5 mg/kg) on day 6 were stained with anti-F4/80 antibody and visualized by confocal microscopy. Scale bar = 50 µm. Shown are representative images from 6 slides with n = 3 biologically independent animals from 2 independent experiments. Figure 11 . Accumulation of HABN in macrophages in the lamina propria. After lamina propria mononuclear cells were incubated in vitro with 10 µg/ml HABN-Cy5.5 for 3 h, particle uptake was analyzed by flow cytometry. Data are presented as mean ± s.e.m. from a representative experiment (n = 3 biologically independent samples) from 2 independent experiments. Figure 12 . CD44-HA interactions mediate association of HABN-Cy5.5 among M1 macrophages. a, Confocal microscopy XYZ images of J774A.1 macrophage cells pre-treated for 24 h with culture medium, LPS (100 ng/ml) and IFN-g (10 ng/ml), or IL-4 (20 ng/ml), followed by 1 hr incubation with Nile red@HABN (Nile Red, 100 ng/ml; HABN 2.5 µg/ml). b, M1-type macrophages were pre-treated for 1 h with or without free HA (5 mg/ml). DAPI was used for nuclei counter staining. Scale bars = 20 µm (a) or 15 µm (b). Confocal microscopy XYZ images of J774A.1 macrophage cells pre-treated for 24 h with culture medium, LPS (100 ng/ml) and IFN-g (10 ng/ml), or IL-4 (20 ng/ml), followed by 1 hr incubation with 100K HABN-Cy5.5 (5 µg/ml). M1-type macrophages were pre-treated for 1 h with anti-CD44 antibody (500 µg/ml). c, J774A.1 macrophage cells were pre-treated with culture medium, LPS (100 ng/ml) and IFN-g (10 ng/ml), or IL-4 (20 ng/ml) for 24 h and incubated with HABN-Cy5.5 (5 µg/ml) for 1 h, followed by confocal microscopy. d, J774A.1 cells were pre-treated with LPS (100 ng/ml) and IFN-g (10 ng/ml) for 24 h, incubated with or without anti-CD44 antibody (500 µg/ml) for 1 h, followed by treatment with HABN-Cy5.5 (5 µg/ml) for 1 h. Scale bars = 15 µm (a-b), 20 µm (c), or 15 µm (d). DAPI was used for nuclei counter staining. Scale bar = 15 µm. Shown are representative images from 6 slides with n = 3 biologically independent samples from 2 independent experiments. Figure 13 . HABN ameliorates colonic damage in a murine model of colitis. a, C57BL/6 mice were provided with 3% DSS in drinking water for 6 days. On days 0, 2, 4, and 6, the animals were orally administered with PBS or 30 mg/kg of HABNs (10K, 100K, or 700K, equivalent mass of HA). b, Daily bodyweight changes in each group for 9 days. c, Colon length was measured on day 9, and d, colon sections stained with hematoxylin and eosin (H&E) were analyzed for colonic damage scores. e, Colonic MPO activity was measured. Data are presented as mean ± s.e.m. from a representative experiment (n = 5 biologically independent animals) from 2 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, analyzed by (c,d,e) one-way or (b) two-way ANOVA with Tukey's HSD multiple comparison post hoc test. Figure 14. A scheme for the synthesis of PEGylated bilirubin (PEG-BR). Supplementary Figure 15 . NMR spectra of PEG-BR and BR. Supplementary Figure 16 . HABN, but not HAoxBR, protects animals against DSS-induced colitis. a, C57BL/6 mice were provided with water or 3% DSS-containing water for 6 days. On days 0, 2, 4, and 6, mice were orally administered with PBS or 30 mg/kg of HABN or HAoxBR. b, Daily bodyweight changes in each group for 9 days. c-e, On day 9, animals were euthanized, and (c) colon length, (d) colonic damage scores, and (e) colonic MPO activity were measured. Data are presented as mean ± s.e.m. from a representative experiment (n = 5 biologically independent animals) from 2 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, analyzed by (c,e) one-way or (b,d) two-way ANOVA with Tukey's HSD multiple comparison post hoc test. Supplementary Figure 22 . Broad-spectrum oral antibiotics disrupt gut microbiome. C57BL/6 mice were pre-treated for 5 days with a cocktail of antibiotics (ampicillin, metronidazole, vancomycin, and neomycin) added to the drinking water and then feces were analyzed for the total bacterial burden by measuring universal eubacterial DNA with qPCR. *p < 0.05, analyzed by Student's unpaired, two-sided t-test. Data are presented as mean ± s.e.m. from a representative experiment (n = 4 biologically independent animals) from 2 independent experiments. 
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